Navigation Links
NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually
Date:12/8/2011

ZURICH, December 9, 2011 /PRNewswire/ --

NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System

Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports innovators, commissioners, and clinicians to speed up the development and use of innovations that will benefit the NHS.

Brian Winn, Head of the National Innovation Centre, explains, "Sequana Medical's ALFApump System is a revolutionary fluid management solution for patients with ascites which could save the NHS significant amounts of money by eliminating the costs associated with repeat medical interventions whilst significantly improving patients' Quality of Life."

The ALFApump System is indicated for the management of refractory and recurrent ascites due to liver cirrhosis, a condition where massive and uncontrolled fluid accumulation occurs in the abdominal cavity. The fully implantable battery powered pump system slowly removes ascites as it forms by transferring it to the bladder where it is eliminated through normal urination.  This condition affects around 3,000 people in the UK a year.

Rajiv Jalan, Professor of Hepatology, UCL, and Honorary Consultant, Royal Free Hospital, London, comments, "The ALFApump System is an exciting innovation in the care of refractory ascites patients for whom current treatment options are very limited."  

Patients are typically managed with large-volume paracentesis, an invasive procedure in which the ascites is drained over a number of hours through a large needle inserted in the abdomen.

Dr Farzana Malik, Vice President of Market Access at Sequana Medical explains, "I am delighted that the National Innovation Centre has recognized the considerable economic benefits to the NHS offered by the ALFApump System. This is a unique technology that provides significant benefits for patients, clinicians and the NHS."

The ALFApump System was granted CE Mark in July 2011 and is currently being launched in leading hepatology centres across Europe by Sequana Medical.

About Sequana Medical:

Sequana Medical is a Swiss medical device company dedicated to improving patient lives through innovative technologies to manage fluid within the body.

Contact:
Sequana Medical
Emily Woodward
Product Marketing Manager
Emily.woodward@sequanamedical.com
Tel: +41-44-446-5074
http://www.sequanamedical.com



'/>"/>
SOURCE Sequana Medical AG
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IBM Contributes Data to the National Institutes of Health to Speed Drug Discovery and Cancer Research Innovation
2. New MediCare International Excess Options Give up to 50% Premium Discount
3. Pepscan Therapeutics Presents Protein Mimicry Platform for the Discovery of anti-GPCR Antibodies at International Antibody Conference
4. Chindex International, Inc. to Present at the 22nd Annual Oppenheimer Healthcare Conference
5. National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week
6. National Influenza Vaccination Week is December 4 - 10, 2011
7. Bupa International Releases Health Guides to Hong Kong and Singapore
8. Leading Indian CRO Max Neeman International Expands in Response to Positive Biosimilars Market in India
9. National Coalition Continues Fight to Stop the Express Scripts/Medco Merger in Nations Capitol
10. Tom Hall Named National Sales and Marketing Director for VR Laboratories
11. Instrumentation Laboratory Introduces Automated HemosIL VWF Ristocetin Cofactor Activity Assay in Europe and International Regions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... Dec. 5 2016 United Kingdom Ophthalmic ... GlobalData,s new report, "United Kingdom Ophthalmic Diagnostic ... data on the United Kingdom Ophthalmic Diagnostic Equipment ... US dollars, volume (in units) and average prices ... (OCT), Retinal Ultrasound Imaging Systems, Corneal Topography Systems, ...
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., a ... data from two Phase I trials evaluating its ... 58th annual meeting of the American Society of ... . The two datasets show encouraging efficacy ... leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell NHL), ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway ... now offering HIAC particle counting and sizing services for USP 788 and 789 ... the new service as a response to the needs of pharmaceutical and medical ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... 'Tis the ... disrupt daily routines. That means it's also the season when eating healthy, staying active, ... with diabetes) on schedule is harder to do. , "Shopping trips, parties and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the only authorized OSHA Training Institute Education Center headquartered in Northern California, has ... focused on providing occupational safety and health training to public sector employees. , ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Surgery, is excited to announce the arrival of the newest Sciton laser in ... the ability to use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming ...
(Date:12/5/2016)... ... 05, 2016 , ... Researchers at Johns Hopkins All Children’s Hospital want to ... Over the course of three years, researchers will study concussions and changes in brain ... equipped with special sensors, will track the location and force of the hit. The ...
Breaking Medicine News(10 mins):